Palmitoylethanolamide (Pea) for Immune Function

Research suggests that PEA interacts meaningfully with immune and inflammatory signaling pathways, though the available evidence on this specific topic is indirect and preliminary. The three studies reviewed here include a mouse model examining PEA's role in neuroimmune reprogramming following drug exposure, a methodological validation study focused on accurately measuring PEA and related compounds in human blood, and a cell and animal study exploring how lipid-based anti-inflammatory signaling — including endocannabinoids closely related to PEA — can be modulated to resolve inflammation. None of these studies directly tested PEA supplementation for immune function outcomes in humans, and findings were mixed or neutral in direction, with the mouse study notably highlighting sex-dependent differences in how PEA-related pathways respond to prior chemical exposure. Overall, while the broader endocannabinoid and lipid-resolving system that PEA belongs to appears relevant to immune regulation, the current evidence base reviewed here is too preliminary and methodologically varied to draw conclusions about PEA's effect on human immune function.